Abstract
Congenital heart disease (CHD) accounts for nearly one-third of all congenital defects, and patients often require repeated heart valve replacements throughout their lives, due to failed surgical repairs and lack of durability of bioprosthetic valve implants. This objective of this study is to develop and in vitro test a fetal transcatheter pulmonary valve replacement (FTPVR) using sutureless techniques to attach leaflets, as an option to correct congenital defects such as pulmonary atresia with intact ventricular septum (PA/IVS), in utero. A balloon expandable design was analyzed using computational simulations to identify areas of failure. Five manufactured valves were assembled using the unique sutureless approach and tested in the fetal right heart simulator (FRHS) to evaluate hemodynamic characteristics. Computational simulations showed that the commissural loads on the leaflet material were significantly reduced by changing the attachment techniques. Hemodynamic analysis showed an effective orifice area of 0.08 cm2, a mean transvalvular pressure gradient of 7.52 mmHg, and a regurgitation fraction of 8.42%, calculated over 100 consecutive cardiac cycles. In conclusion, the FTPVR exhibited good hemodynamic characteristics, and studies with biodegradable stent materials are underway.
Similar content being viewed by others
Abbreviations
- PA/IVS:
-
Pulmonary atresia with intact ventricular septum
- TEHV:
-
Tissue engineered heart valve
- FTPVR:
-
Fetal transcatheter pulmonary valve replacement
- TAVR:
-
Transcatheter aortic valve replacement
- Co–Cr:
-
Cobalt–chromium
- FE:
-
Finite element
- PCL:
-
Polycaprolactone
- FRHS:
-
Fetal right heart simulator
- EOA:
-
Effective orifice area
- RF:
-
Regurgitation fraction
- CV:
-
Closing volume
- LV:
-
Leakage volume
- FV:
-
Forward volume
References
van der Linde, D., E. E. M. Konings, M. A. Slager, M. Witsenburg, W. A. Helbing, J. J. M. Takkenberg, and J. W. Roos-Hesselink. Birth prevalence of congenital heart disease worldwide a systematic review and meta-analysis. J. Am. Coll. Cardiol. 58(21):2241–2247, 2011. https://doi.org/10.1016/j.jacc.2011.08.025.
Farmer, D., N. Sitkin, K. Lofberg, P. Donkor, and D. Ozgediz. Surgical interventions for congenital anomalies. In: Essential Surgery: Disease Control Priorities, Vol. 1, 3rd ed., edited by H. T. Debas, P. Donkor, A. Gawande, D. T. Jamison, M. E. Kruk, and C. N. Mock. Washington: The International Bank for Reconstruction and Development/The World Bank, 2015.
Gorla, S. R., and A. P. Singh. Pulmonary Atresia With Intact Ventricular Septum. Treasure Island: StatPearls, 2022.
Najm, H. K., W. G. Williams, J. G. Coles, I. M. Rebeyka, and R. M. Freedom. Pulmonary atresia with intact ventricular septum: results of the Fontan procedure. Ann Thorac. Surg. 63(3):669–675, 1997. https://doi.org/10.1016/s0003-4975(96)01366-5.
Bautista-Hernandez, V., B. S. Hasan, D. M. Harrild, A. Prakash, D. Porras, J. E. Mayer Jr., P. J. del Nido, and F. A. Pigula. Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann. Thorac. Surg. 91(2):555–560, 2011. https://doi.org/10.1016/j.athoracsur.2010.09.024.
Freeman, J. E., S. Y. DeLeon, S. Lai, E. A. Fisher, E. P. Ow, and R. Pifarre. Right ventricle-to-aorta conduit in pulmonary atresia with intact ventricular septum and coronary sinusoids. Ann. Thorac. Surg. 56(6):1393–1395, 1993. https://doi.org/10.1016/0003-4975(93)90691-a.
Manavitehrani, I., P. Ebrahimi, I. Yang, S. Daly, A. Schindeler, A. Saxena, D. G. Little, D. F. Fletcher, F. Dehghani, and D. S. Winlaw. Current challenges and emergent technologies for manufacturing artificial right ventricle to pulmonary artery (RV-PA) cardiac conduits. Cardiovasc. Eng. Technol. 10(2):205–215, 2019. https://doi.org/10.1007/s13239-019-00406-5.
Selcuk, A., Y. Kilic, O. Korun, O. Yurdakok, M. Cicek, H. F. Altin, Y. Altuntas, E. H. Yilmaz, A. Sasmazel, and N. A. Aydemir. High incidence of fever in patients after biointegral pulmonic valved conduit implantation. J. Card Surg. 36(9):3147–3152, 2021. https://doi.org/10.1111/jocs.15683.
Williams, D. F., D. Bezuidenhout, J. de Villiers, P. Human, and P. Zilla. Long-term stability and biocompatibility of pericardial bioprosthetic heart valves. Front. Cardiovasc. Med.8:728577, 2021. https://doi.org/10.3389/fcvm.2021.728577.
Kostyunin, A. E., A. E. Yuzhalin, M. A. Rezvova, E. A. Ovcharenko, T. V. Glushkova, and A. G. Kutikhin. Degeneration of bioprosthetic heart valves: update 2020. J. Am. Heart Assoc.9(19):e018506, 2020. https://doi.org/10.1161/JAHA.120.018506.
Devanagondi, R., D. Peck, J. Sagi, J. Donohue, S. Yu, S. K. Pasquali, and A. K. Armstrong. Long-term outcomes of balloon valvuloplasty for isolated pulmonary valve stenosis. Pediatr. Cardiol. 38(2):247–254, 2017. https://doi.org/10.1007/s00246-016-1506-4.
Boe, B. A., J. D. Zampi, K. F. Kennedy, N. Jayaram, D. Porras, S. R. Foerster, and A. K. Armstrong. Acute success of balloon aortic valvuloplasty in the current era: a national cardiovascular data registry study. JACC Cardiovasc. Interv. 10(17):1717–1726, 2017. https://doi.org/10.1016/j.jcin.2017.08.001.
Freud, L. R., D. B. McElhinney, A. C. Marshall, G. R. Marx, K. G. Friedman, P. J. del Nido, S. M. Emani, T. Lafranchi, V. Silva, L. E. Wilkins-Haug, C. B. Benson, J. E. Lock, and W. Tworetzky. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation. 130(8):638–645, 2014. https://doi.org/10.1161/CIRCULATIONAHA.114.009032.
Rao, P. S., M. K. Thapar, and F. Kutayli. Causes of restenosis after balloon valvuloplasty for valvular pulmonary stenosis. Am. J. Cardiol. 62(13):979–982, 1988. https://doi.org/10.1016/0002-9149(88)90909-5.
Ozme, S., A. Celiker, S. Ozkutlu, S. Ozer, and K. Baysal. Percutaneous transluminal balloon pulmonary valvuloplasty: immediate and medium-term results. Turk. J. Pediatr. 32(1):25–31, 1990.
Zakko, J., K. M. Blum, J. D. Drews, Y. L. Wu, H. Hatoum, M. Russell, S. Gooden, M. Heitkemper, O. Conroy, J. Kelly, S. Carey, M. Sacks, K. Texter, E. Ragsdale, J. Strainic, M. Bocks, Y. Wang, L. P. Dasi, A. K. Armstrong, and C. Breuer. Development of tissue engineered heart valves for percutaneous transcatheter delivery in a fetal ovine model. JACC Basic Transl. Sci. 5(8):815–828, 2020. https://doi.org/10.1016/j.jacbts.2020.06.009.
Schwarz, E. L., J. M. Kelly, K. M. Blum, K. N. Hor, A. R. Yates, J. C. Zbinden, A. Verma, S. E. Lindsey, A. B. Ramachandra, J. M. Szafron, J. D. Humphrey, T. Shin’oka, A. L. Marsden, and C. K. Breuer. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. Npj Regen. Med. 6(1):38, 2021. https://doi.org/10.1038/s41536-021-00157-9.
Blum, K. M., J. C. Zbinden, A. B. Ramachandra, S. E. Lindsey, J. M. Szafron, J. W. Reinhardt, M. Heitkemper, C. A. Best, G. J. M. Mirhaidari, Y. C. Chang, A. Ulziibayar, J. Kelly, K. V. Shah, J. D. Drews, J. Zakko, S. Miyamoto, Y. Matsuzaki, R. Iwaki, H. Ahmad, R. Daulton, D. Musgrave, M. G. Wiet, E. Heuer, E. Lawson, E. Schwarz, M. R. McDermott, R. Krishnamurthy, R. Krishnamurthy, K. Hor, A. K. Armstrong, B. A. Boe, D. P. Berman, A. J. Trask, J. D. Humphrey, A. L. Marsden, T. Shinoka, and C. K. Breuer. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun. Med. (Lond.). 2:3, 2022. https://doi.org/10.1038/s43856-021-00063-7.
Drews, J. D., V. K. Pepper, C. A. Best, J. M. Szafron, J. P. Cheatham, A. R. Yates, K. N. Hor, J. C. Zbinden, Y. C. Chang, G. J. M. Mirhaidari, A. B. Ramachandra, S. Miyamoto, K. M. Blum, E. A. Onwuka, J. Zakko, J. Kelly, S. L. Cheatham, N. King, J. W. Reinhardt, T. Sugiura, H. Miyachi, Y. Matsuzaki, J. Breuer, E. D. Heuer, T. A. West, T. Shoji, D. Berman, B. A. Boe, J. Asnes, M. Galantowicz, G. Matsumura, N. Hibino, A. L. Marsden, J. S. Pober, J. D. Humphrey, T. Shinoka, and C. K. Breuer. Spontaneous reversal of stenosis in tissue-engineered vascular grafts. Sci. Transl. Med. 12(537):eaax6919, 2020. https://doi.org/10.1126/scitranslmed.aax6919.
Heitkemper, M., H. Hatoum, and L. P. Dasi. In vitro hemodynamic assessment of a novel polymeric transcatheter aortic valve. J. Mech. Behav. Biomed. 98:163–171, 2019. https://doi.org/10.1016/j.jmbbm.2019.06.016.
Hatoum, H., S. Gooden, M. Heitkemper, K. M. Blum, J. Zakko, M. Bocks, T. Yi, Y. L. Wu, Y. D. Wang, C. K. Breuer, and L. P. Dasi. Fetal transcatheter trileaflet heart valve hemodynamics: implications of scaling on valve mechanics and turbulence. Ann. Biomed. Eng. 48(6):1683–1693, 2020. https://doi.org/10.1007/s10439-020-02475-3.
Johnson, P., D. J. Maxwell, M. J. Tynan, and L. D. Allan. Intracardiac pressures in the human fetus. Heart. 84(1):59–63, 2000. https://doi.org/10.1136/heart.84.1.59.
Yoganathan, A. P., Z. M. He, and S. C. Jones. Fluid mechanics of heart valves. Annu. Rev. Biomed. Eng. 6:331–362, 2004. https://doi.org/10.1146/annurev.bioeng.6.040803.140111.
Hui, S., F. Mahmood, and R. Matyal. Aortic valve area-technical communication: continuity and gorlin equations revisited. J. Cardiothorac. Vasc. Anesth. 32(6):2599–2606, 2018. https://doi.org/10.1053/j.jvca.2018.05.027.
Leroux, A., T. Ngoc Nguyen, A. Rangel, I. Cacciapuoti, D. Duprez, D. G. Castner, and V. Migonney. Long-term hydrolytic degradation study of polycaprolactone films and fibers grafted with poly(sodium styrene sulfonate): mechanism study and cell response. Biointerphases.15(6):061006, 2020. https://doi.org/10.1116/6.0000429.
Acknowledgments
This study was supported with funds from Additional Ventures (Grant No. GR00006544). The authors acknowledge the use of ABAQUS software provided through the Cardiovascular Fluid Mechanics Laboratory at Georgia Tech.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Associate Editor Elizabeth Cosgriff-Hernandez oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bhat, S.S., Bui, H.T., Farnan, A. et al. Development of Novel Sutureless Balloon Expandable Fetal Heart Valve Device Using Absorbable Polycaprolactone Leaflets. Ann Biomed Eng 52, 386–395 (2024). https://doi.org/10.1007/s10439-023-03386-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-023-03386-9